# Pregabalin (Lyrica)

Page: https://stenobird.com/podcast/psychrounds-the-psychiatry-podcast-6714703/pregabalin-lyrica
Text version: https://stenobird.com/podcast/psychrounds-the-psychiatry-podcast-6714703/pregabalin-lyrica.md
Podcast: [PsychRounds: The Psychiatry Podcast](https://stenobird.com/podcast/psychrounds-the-psychiatry-podcast-6714703)
Published: 2025-09-24T05:00:00+00:00
Episode link: https://podcasters.spotify.com/pod/show/psychrounds/episodes/Pregabalin-Lyrica-e37ng97
Audio file: https://anchor.fm/s/eb936048/podcast/play/107773671/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2025-8-3%2F33021a81-8bca-df91-f250-426e23f43393.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/psychrounds-the-psychiatry-podcast-6714703/episodes/pregabalin-lyrica
Duration seconds: 860

## Resource

Welcome back! Today, we will be talking about Pregabalin, brand-name Lyrica, a similar medication to Gabapentin, and we will specifically be focusing on its use in psychiatry. What are its benefits and drawbacks compared to Gabapentin? Sources: - https://pubmed.ncbi.nlm.nih.gov/33563173/ - https://pubmed.ncbi.nlm.nih.gov/39989902/ - https://pmc.ncbi.nlm.nih.gov/articles/PMC3699256/ - https://pubmed.ncbi.nlm.nih.gov/33563173/

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/psychrounds-the-psychiatry-podcast-6714703/episodes/pregabalin-lyrica/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/psychrounds-the-psychiatry-podcast-6714703/pregabalin-lyrica.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.